The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Pawankumar Suresh enhances early-stage drug research processes, ensuring regulatory compliance through effective systems and vendor governance.

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

A new AI breakthrough could slash the time it takes to discover life-saving medicines, according to researchers in ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...

Pfizer’s CEO Albert Bourla is looking to initiate about 10 late-stage trials of the company’s new obesity drugs.

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...